Compare · BLLN vs HUM
BLLN vs HUM
Side-by-side comparison of BillionToOne Inc. (BLLN) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BLLN and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $54.05B, about 10.8x BLLN ($5.02B).
- BLLN has been more active in the news (13 items in the past 4 weeks vs 12 for HUM).
- HUM has more recent analyst coverage (25 ratings vs 9 for BLLN).
- Company
- BillionToOne Inc.
- Humana Inc.
- Price
- -
- -
- Market cap
- $5.02B
- $54.05B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 13
- 12
- Recent ratings
- 9
- 25
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest BLLN
- Director Kolluri Krishna Kittu disposed of 505,925 shares and acquired 108,433 shares (SEC Form 4)
- Norwest Announces $4 Billion Global, Multi-Stage Fund
- Director Ileri Firat covered exercise/tax liability with 436 shares, decreasing direct ownership by 1% to 39,895 units (SEC Form 4) (tax liability)
- Amendment: SEC Form SCHEDULE 13D/A filed by BillionToOne Inc.
- SEC Form 4 filed by BillionToOne Inc.
- SEC Form 4 filed by BillionToOne Inc.
- Chief Technology Officer Tsao David exercised 20,000 shares at a strike of $2.80 and sold $2,184,854 worth of shares (20,000 units at $109.24) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 10-Q filed by BillionToOne Inc.
- BillionToOne Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- BillionToOne Reports Third Quarter 2026 Results and Raises 2026 Revenue Guidance
Latest HUM
- Humana upgraded by RBC Capital Mkts with a new price target
- Director Frederick Wayne A.I. sold $193,853 worth of Humana Common (440 units at $440.57), closing all direct ownership in the company (SEC Form 4)
- President, Enterprise Growth Dintenfass David gifted 230 units of Humana Common, decreasing direct ownership by 0.91% to 25,177 units (SEC Form 4)
- Chief Legal Officer Ventura Joseph C sold $2,384,013 worth of Humana Common (5,495 units at $433.85) and gifted 437 units of Humana Common, decreasing direct ownership by 22% to 21,473 units (SEC Form 4)
- New oncology model from Humana, Evolent and American Oncology Network eliminates prior authorization burden
- Humana Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open Enrollment
- Humana Commences Offers to Purchase for Cash Certain of its Outstanding Debt Securities
- SEC Form 10-Q filed by Humana Inc.
- Humana Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits